Inhibitory Mechanism of Combined Hydroxychavicol With Epigallocatechin-3-Gallate Against Glioma Cancer Cell Lines: A Transcriptomic Analysis

Emerging reports have shown therapeutic potential of hydroxychavicol (HC) and epigallocatechin-3-gallate (EGCG) against cancer cells, however high concentrations are required to achieve the anticancer activity. We reported the synergy of low combination doses of EGCG+HC in glioma cell lines 1321N1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Rahman, Amirah, Wan Ngah, Wan Zurinah, Jamal, Rahman, Makpol, Suzana, Harun, Roslan, Mokhtar, Norfilza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982671/
https://www.ncbi.nlm.nih.gov/pubmed/35392560
http://dx.doi.org/10.3389/fphar.2022.844199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982671/
https://www.ncbi.nlm.nih.gov/pubmed/35392560
http://dx.doi.org/10.3389/fphar.2022.844199

Ejemplares similares